Abstract
Carfilzomib (CFZ), a Novel Proteasome Inhibitor for Relapsed or Refractory Multiple Myeloma, Is Associated with Minimal Peripheral Neuropathic Effects.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have